Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 10999

Original article / research
Table of Contents - Year : 2017 | Month : March | Volume : 11 | Issue : 3 | Page : OC21 - OC24

An Assessment of Osteoporotic Conditions among Users and Non-Users of Warfarin: A Case-Control Study OC21-OC24

Aseel Hadi Abdulameer, Syed Azhar Bin Syed Sulaiman, Muhamad Bin Sk Abdul Kader

Correspondence
Mrs. Aseel Hadi Abdulameer,
Postgraduate Student, Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia,
Penang-11800, Malaysia.
E-mail: ahmed2010y66@yahoo.com

Introduction: Warfarin is an oral anticoagulant which is associated with a decrease in Bone Mass Density (BMD).

Aim: The study aimed to explore the prevalence of osteoporosis conditions in Malaysians with chronic warfarin patients using calcaneal quarter of Quantitative Ultrasound (QUS) machine and to investigate whether long-term sodium warfarin therapy that antagonizes vitamin K is affecting the increasing rate of osteoporosis in Penang and to find the risk factors of getting osteoporosis among warfarin users and its non users.

Materials and Methods: A case-control study was conducted among 130 patients using warfarin, attending the outpatient clinic at Hospital Pulau Pinang. A convenience sampling method was used to recruit the required sample. Another 140 subjects were selected from the community as a control group (non-users of warfarin).

Results: This study showed that more than three-quarter patients (82%) were at high risk of abnormal BMD. The warfarin users were two times more likely to have a higher osteoporosis risk compared to control group. Moreover, BMD has a negative correlation with age, but has a positive correlation with Body Mass Index (BMI). Patients showed a negative correlation with a higher dose of warfarin intake.

Conclusion: This study concluded that osteopenia and osteoporosis are serious problems between users and non-users warfarin in Penang. Therefore, it should be taken into consideration in the Malaysian Health Ministry’s agenda.